XML 79 R69.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidating Financial Information (Condensed Consolidating Statement of Cash Flows) (Details) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2017
Oct. 01, 2016
Cash flows from operating activities: [Abstract]    
Net cash provided by (used in) operating activities of continuing operations $ (6,164) $ 3,279
Net cash (used in) provided by operating activities of discontinued operations (3,447) 2,076
Net cash (used in) provided by operating activities (9,611) 5,355
Cash flows from investing activities:    
Capital expenditures (19,922) (29,118)
Proceeds from sale of property, plant and equipment 1,265 8,272
Premiums for company owned life insurance policies, net (410) (245)
Proceeds from sale of assets 0 2,000
Net cash used in investing activities of continuing operations (19,067) (19,091)
Net cash (used in) provided by investing activities of discontinued operations (201) 92,309
Net cash (used in) provided by investing activities (19,268) 73,218
Cash flows from financing activities:    
Proceeds from issuance of 4% secured notes due 2021 0 50,000
Payment of financing-related costs and expenses and debt issuance discounts (398) (12,182)
Proceeds from issuance of other long-term debt 11,646 0
Repayments of other long-term debt (4,756) (4,115)
Repayment of 11.5% senior notes due 2017 (20,465) (4,725)
Repayment of 7% senior exchangeable notes due 2017 (5,493) (40,207)
Purchase and retirement of common stock upon vesting of restricted stock units (55) (341)
Borrowings under asset-based revolving credit facility due 2021 311,054 368,600
Repayments under asset-based revolving credit facility due 2021 (261,966) (441,700)
Intercompany advances 0 0
Net cash provided by (used in) financing activities of continuing operations 29,567 (84,670)
Net cash used in financing activities of discontinued operations 0 (8)
Net cash provided by (used in) financing activities 29,567 (84,678)
Effect of exchange rate changes on cash and cash equivalents 86 443
Net increase (decrease) in cash and cash equivalents 774 (5,662)
Cash and cash equivalents at beginning of period 5,532 10,556
Cash and cash equivalents at end of period 6,306 4,894
Parent Company [Member]    
Cash flows from operating activities: [Abstract]    
Net cash provided by (used in) operating activities of continuing operations 619 1,230
Net cash (used in) provided by operating activities of discontinued operations 0 0
Net cash (used in) provided by operating activities 619 1,230
Cash flows from investing activities:    
Capital expenditures 0 0
Proceeds from sale of property, plant and equipment 0 0
Premiums for company owned life insurance policies, net 0 0
Proceeds from sale of assets   0
Net cash used in investing activities of continuing operations 0 0
Net cash (used in) provided by investing activities of discontinued operations 0 0
Net cash (used in) provided by investing activities 0 0
Cash flows from financing activities:    
Proceeds from issuance of 4% secured notes due 2021   0
Payment of financing-related costs and expenses and debt issuance discounts 0 0
Proceeds from issuance of other long-term debt 0  
Repayments of other long-term debt 0 0
Repayment of 11.5% senior notes due 2017 0 0
Repayment of 7% senior exchangeable notes due 2017 0 0
Purchase and retirement of common stock upon vesting of restricted stock units (55) (341)
Borrowings under asset-based revolving credit facility due 2021 0 0
Repayments under asset-based revolving credit facility due 2021 0 0
Intercompany advances (564) (889)
Net cash provided by (used in) financing activities of continuing operations   (1,230)
Net cash used in financing activities of discontinued operations   0
Net cash provided by (used in) financing activities (619) (1,230)
Effect of exchange rate changes on cash and cash equivalents 0 0
Net increase (decrease) in cash and cash equivalents 0 0
Cash and cash equivalents at beginning of period 0 0
Cash and cash equivalents at end of period 0 0
Subsidiary Issuer [Member]    
Cash flows from operating activities: [Abstract]    
Net cash provided by (used in) operating activities of continuing operations (34,202) (91,850)
Net cash (used in) provided by operating activities of discontinued operations (3,447) 12,586
Net cash (used in) provided by operating activities (37,649) (79,264)
Cash flows from investing activities:    
Capital expenditures (11,391) (12,262)
Proceeds from sale of property, plant and equipment 1,265 8,131
Premiums for company owned life insurance policies, net (410) (245)
Proceeds from sale of assets   0
Net cash used in investing activities of continuing operations (10,536) (4,376)
Net cash (used in) provided by investing activities of discontinued operations (201) (2,055)
Net cash (used in) provided by investing activities (10,737) (6,431)
Cash flows from financing activities:    
Proceeds from issuance of 4% secured notes due 2021   50,000
Payment of financing-related costs and expenses and debt issuance discounts (398) (12,182)
Proceeds from issuance of other long-term debt 11,646  
Repayments of other long-term debt (7,827) (4,136)
Repayment of 11.5% senior notes due 2017 (20,465) (4,725)
Repayment of 7% senior exchangeable notes due 2017 (5,493) (40,207)
Purchase and retirement of common stock upon vesting of restricted stock units 0 0
Borrowings under asset-based revolving credit facility due 2021 311,054 368,600
Repayments under asset-based revolving credit facility due 2021 (261,966) (441,700)
Intercompany advances 22,962 169,051
Net cash provided by (used in) financing activities of continuing operations   84,701
Net cash used in financing activities of discontinued operations   0
Net cash provided by (used in) financing activities 49,513 84,701
Effect of exchange rate changes on cash and cash equivalents 0 0
Net increase (decrease) in cash and cash equivalents 1,127 (994)
Cash and cash equivalents at beginning of period 4,678 5,558
Cash and cash equivalents at end of period 5,805 4,564
Guarantor Subsidiaries [Member]    
Cash flows from operating activities: [Abstract]    
Net cash provided by (used in) operating activities of continuing operations 26,349 92,403
Net cash (used in) provided by operating activities of discontinued operations 0 (10,072)
Net cash (used in) provided by operating activities 26,349 82,331
Cash flows from investing activities:    
Capital expenditures (7,849) (16,255)
Proceeds from sale of property, plant and equipment 0 141
Premiums for company owned life insurance policies, net 0 0
Proceeds from sale of assets   2,000
Net cash used in investing activities of continuing operations (7,849) (14,114)
Net cash (used in) provided by investing activities of discontinued operations 0 87,877
Net cash (used in) provided by investing activities (7,849) 73,763
Cash flows from financing activities:    
Proceeds from issuance of 4% secured notes due 2021   0
Payment of financing-related costs and expenses and debt issuance discounts 0 0
Proceeds from issuance of other long-term debt 0  
Repayments of other long-term debt 3,071 21
Repayment of 11.5% senior notes due 2017 0 0
Repayment of 7% senior exchangeable notes due 2017 0 0
Purchase and retirement of common stock upon vesting of restricted stock units 0 0
Borrowings under asset-based revolving credit facility due 2021 0 0
Repayments under asset-based revolving credit facility due 2021 0 0
Intercompany advances (21,657) (159,218)
Net cash provided by (used in) financing activities of continuing operations   (159,197)
Net cash used in financing activities of discontinued operations   (8)
Net cash provided by (used in) financing activities (18,586) (159,205)
Effect of exchange rate changes on cash and cash equivalents 86 316
Net increase (decrease) in cash and cash equivalents 0 (2,795)
Cash and cash equivalents at beginning of period 0 3,006
Cash and cash equivalents at end of period 0 211
Non-Guarantor Subsidiaries [Member]    
Cash flows from operating activities: [Abstract]    
Net cash provided by (used in) operating activities of continuing operations 1,070 1,496
Net cash (used in) provided by operating activities of discontinued operations 0 (438)
Net cash (used in) provided by operating activities 1,070 1,058
Cash flows from investing activities:    
Capital expenditures (682) (601)
Proceeds from sale of property, plant and equipment 0 0
Premiums for company owned life insurance policies, net 0 0
Proceeds from sale of assets   0
Net cash used in investing activities of continuing operations (682) (601)
Net cash (used in) provided by investing activities of discontinued operations 0 6,487
Net cash (used in) provided by investing activities (682) 5,886
Cash flows from financing activities:    
Proceeds from issuance of 4% secured notes due 2021   0
Payment of financing-related costs and expenses and debt issuance discounts 0 0
Proceeds from issuance of other long-term debt 0  
Repayments of other long-term debt 0 0
Repayment of 11.5% senior notes due 2017 0 0
Repayment of 7% senior exchangeable notes due 2017 0 0
Purchase and retirement of common stock upon vesting of restricted stock units 0 0
Borrowings under asset-based revolving credit facility due 2021 0 0
Repayments under asset-based revolving credit facility due 2021 0 0
Intercompany advances (741) (8,944)
Net cash provided by (used in) financing activities of continuing operations   (8,944)
Net cash used in financing activities of discontinued operations   0
Net cash provided by (used in) financing activities (741) (8,944)
Effect of exchange rate changes on cash and cash equivalents 0 127
Net increase (decrease) in cash and cash equivalents (353) (1,873)
Cash and cash equivalents at beginning of period 854 1,992
Cash and cash equivalents at end of period 501 119
Eliminations [Member]    
Cash flows from operating activities: [Abstract]    
Net cash provided by (used in) operating activities of continuing operations 0 0
Net cash (used in) provided by operating activities of discontinued operations 0 0
Net cash (used in) provided by operating activities 0 0
Cash flows from investing activities:    
Capital expenditures 0 0
Proceeds from sale of property, plant and equipment 0 0
Premiums for company owned life insurance policies, net 0 0
Proceeds from sale of assets   0
Net cash used in investing activities of continuing operations 0 0
Net cash (used in) provided by investing activities of discontinued operations 0 0
Net cash (used in) provided by investing activities 0 0
Cash flows from financing activities:    
Proceeds from issuance of 4% secured notes due 2021   0
Payment of financing-related costs and expenses and debt issuance discounts 0 0
Proceeds from issuance of other long-term debt 0  
Repayments of other long-term debt 0 0
Repayment of 11.5% senior notes due 2017 0 0
Repayment of 7% senior exchangeable notes due 2017 0 0
Purchase and retirement of common stock upon vesting of restricted stock units 0 0
Borrowings under asset-based revolving credit facility due 2021 0 0
Repayments under asset-based revolving credit facility due 2021 0 0
Intercompany advances 0 0
Net cash provided by (used in) financing activities of continuing operations   0
Net cash used in financing activities of discontinued operations   0
Net cash provided by (used in) financing activities 0 0
Effect of exchange rate changes on cash and cash equivalents 0 0
Net increase (decrease) in cash and cash equivalents 0 0
Cash and cash equivalents at beginning of period 0 0
Cash and cash equivalents at end of period $ 0 $ 0